Caladrius Biosciences Inc. (CLBS) Climbed 18.99% or 0.75 To Price $4.7 On Tuesday


Caladrius Biosciences Inc. (CLBS) climbed 18.99% or 0.75 to $4.7. It is near 922314 shares traded, which is 3436.6% compare to the average total volume 26838. The market cap of CLBS is $44.98 million. The year to date change is 25.74%. The 52 week price range is from $2.63 to $6.35. Price of CLBS have changed 0.51% during last week. It have changed -7.06% over last month, -33.72% over last 3 months, 16.18% over last 6 months and -9.40% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 4.25. It is -9.57% below current price. The 200-day Moving Averages for CLBS is 4.06. It is -13.62% below current price. The 52-week High is 6.35. It is 35.11% from the current price. The 52-week Low is 2.63. It is -44.04% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLBS is 0.49 on 2018-05-31. Short % to float is 0.53%. There are some statistics of CLBS. It is has market cap $44.98 million. The share outstanding is 9.57 million. The average volume is 26838. It has 118.82M cash and 961196 in debt. The percent of top 15 Institution holding is 5.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is 122.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is 48.47%.


Tags:

Share this post